Pfizer is leading a turnaround effort, which has been discussed in the context of the company's stock performance ahead of earnings.
2 reports, 2 independent
Updated Aug 16
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer is leading a turnaround effort, which has been discussed in the context of the company's stock performance ahead of earnings.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Pfizer CEO Albert Bourla provided a strategic outlook on the company's future.Sub-event
Pfizer turnaround effort led by Albert Bourla discussed regarding stock performance.1 source
Keep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Albert Bourla
Greek-American pharmaceutical executive
Nothing else this week.
-
Jim Cramer
American stockbroker, television personality, author
Related events
Coverage
Newest first; wire copies grouped- Insider MonkeyPfizer Inc. (PFE) Comes Up With A Good Thing But No One Cares, Laments Jim Cramer We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Pfizer Inc. (NYSE:PFE) is one of
- Motley Fool3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer Pfizer's free cash flow should improve. The drugmaker's lower leverage ratio target gives it greater financial flexibility. New products shoul